Leishmaniases. Epidemiological Report in the Americas, July 2016
MetadataShow full item record
[Introduction]. The leishmaniases are vector-borne diseases with a zoonotic cycle in the Americas and remain a problem to public health. This disease presents a high burden capable of yielding severe clinical forms that may cause deformities, disabilities and death. Bolivia and Peru are among the countries with the highest global DALYs (Disability Adjusted Life of Years) of cutaneous/mucosal leishmaniasis and Brazil is among the countries with the highest fatality rates for visceral leishmaniasis. In the last five years, the Pan American Health Organization/World Health Organization (PAHO/WHO) has been promoting access to diagnosis and treatment to endemic countries. Furthermore, surveillance actions have been improved and strengthened in order to guide, prioritize activities and establish technical cooperation. Since the implementation of the Leishmaniasis Information System (SisLeish/PAHO/OMS), regional data have been aggregated and consolidated, thus allowing analysis and monitoring of the disease. From the 18 endemic countries, 17 have individual or aggregated mandatory notification for leishmaniasis, and 43.75% (240,635,853) of the population are exposed to the risk.Introduction | Epidemiological status | Visceral leishmaniasis | Final considerations | References
Category of PAHO Strategic Plan 2014-2019
Showing items related by title, author, creator and subject.
Pan American Health Organization; Communicable Diseases and Environmental Determinants of Health (CDE) (Washington, D.C., PAHO, 2020-12-23)In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral ...
Pan American Health Organization; Communicable Diseases and Environmental Determinants of Health (CDE) (Washington, D.C., PAHO, 2020-12-03)In the Americas, leishmaniasis are a public health problem due to their magnitude and geographic distribution and because they produce clinical forms that can cause death, disability, and mutilation. In recent years, the ...
Plan of Action to Strengthen the Surveillance and Control of Leishmaniasis in the Americas 2017-2022 Pan American Health Organization (Washington, D.C, PAHO, 2017-07)[Introduction]. The Leishmaniasis Plan of Action for the Americas is an instrument that consolidates the main lines of action to strengthen surveillance and control of the disease in the Region. Furthermore, it presents ...